Dynavax Technologies Corp.: “Yeah, well, it’s good. I love these little immuno drug stories.”
Nucor Corp.: Buy. “Nucor is coming back. … People think it’s going to earn $22 [per share] this year … [+422 chars]
Cramers lightning round: Nucor is a buy – CNBC